ArticleProceedings of the National Academy of Sciences of the United States of America2026

Small-molecule CBLB inhibitor abolishes EGFR ubiquitination, reduces receptor endocytosis, and diminishes cell motility signaling.

Itziar Pinilla-Macua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.